🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great news today! A phase I protocol was approved by the FDA to treat patients with chronic granulomatous disease (CGD) with functionally corrected granulocutes! Congrats to NIAID and my team that put in so much work on this protocol!

If you are attending SITC in DC and want to learn about how different bioreactors affect function and phenotype of CAR T-cells (presented by Dr. Song) then please stop by our poster abstract #145 Friday 12:40-2:10pm. Hope to see you there!! #sitc2021

Manuscript published today in the Journal of Translational Medicine from a very talented post-bac in my lab! She is looking for a good lab to call home for graduate school in 2022! Remley et al. @vickalicious42

At the NIH Clinical Center, we are thankful for our patients, more than 500,000 since the hospital opened in 1953, and our staff of doctors, researchers, nurses and support personnel. We are all working together to make medical discovery possible! #HappyThanksgiving

News: First U.S. patient receives autologous stem cell therapy to treat dry AMD dlvr.it/SXYd0j

I mean it’s already an amazing effort I’m proud to be a part of to “drive” CARs and make CAR T therapy work better & the great name CARnation!!! Let’s go #ChildhoodCancerAwarenessMonth Nirali Shah Crystal Mackall Sneha Ramakrishna

CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma: buff.ly/3Cmqfu4 #CARTCR #immunotherapy

Recently tested this pretty sweet instrument out as replacement for soon-to-be-retired Elutra. 🤩#invetechkorus #NIHdreamteam

Our super talented post bac - Roshini Traynor - had the chance to share her data today comparing CAR T-cells manufactured from whole blood vs apheresis! Great job!#nihpostbacposterday #nihclinicalcenter

Special thanks to Patrick J. Hanley 🧬 for chairing our roundtable on managing factors affecting CT efficacy! #ISCT2023

Finally got a chance to this beautiful piece of architecture today! #ISCT2023

Rutgers Cancer Center treats 1st patient with its own manufactured T-cells: buff.ly/3rwPBT6 #CARTCR #immunotherapy

Our paper is out! "Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma" cell.com/cell-reports-m…

India's CAR-T cell therapy NexCAR19: How it fights and wins against cancer: buff.ly/49oKS73 #CARTCR

Hot off the press! A new article published in Cytotherapy from my group describing the differences in expansion platforms for CAR T-cells. Check it out 👍 Congrats Hannah W. Song, Ph.D. !! sciencedirect.com/science/articl…

Alka Dwivedi ImmunoACT Rahul Purwar Hasmukh Jain Gaurav Narula MD Nirali Shah @NCI_CCR_PedOnc Amazing achievement!

for all day I have been imagining I detected the presence of cythyl.€o you imagine so now??I asked.es 🚩 🌹 💦 🌺 🎌 🌸 🎈 💎

and at the same time I have no desire to go to extremities.' 'You'll not help your case by threatening me 🎉 🌹 🍀 🌻 🌈